B. Riley Wealth Advisors’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
Other funds holding SNOA
SM
BA
CH
GW
B. Riley Wealth Advisors's SNOA Position: Q4 2018 in Review
B. Riley Wealth Advisors sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2018, closing a stake of 83 shares — an estimated $22K sold.
B. Riley Wealth Advisors first reported a position in SNOA in Q2 2013 and held it in 18 quarters. The position peaked at $203K in Q1 2014. 18 funds tracked by Wall St. Rank hold SNOA as of Q4 2018.
- B. Riley Wealth Advisors reported no remaining Sonoma Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
- B. Riley Wealth Advisors sold 83 Sonoma Pharmaceuticals shares in Q4 2018, an estimated $22K.
- B. Riley Wealth Advisors first reported a position in Sonoma Pharmaceuticals in Q2 2013 and held it in 18 quarters.
- B. Riley Wealth Advisors's Sonoma Pharmaceuticals position peaked at $203K in Q1 2014.
- 18 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2018.
Based on B. Riley Wealth Advisors's 13F filing for Q4 2018, filed 8 Feb 2019.